← Back to Search

Restricted Sleep Impact on Brain Health

N/A
Recruiting
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two days
Awards & highlights

Study Summary

This trial will compare how normal and restricted sleep affects brain blood flow in healthy men and women. Participants will complete 3 visits.

Who is the study for?
This trial is for healthy men and women aged 18-45 with a BMI of 18-30, who don't use nicotine and aren't pregnant or breastfeeding. It's not for those with recent major heart events, high blood pressure, sleep-affecting meds, or history of liver, kidney, lung diseases; stroke; bleeding disorders; sleep apnea; diabetes; or substance abuse.Check my eligibility
What is being tested?
The study looks at how restricted sleep affects brain blood flow in healthy adults. Participants will have their cerebral blood flow velocity measured after normal and restricted sleep nights to see if there's a difference and if the effect varies between males and females over two separate days.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring rather than medication or invasive procedures, significant side effects are not anticipated. However, participants may experience fatigue due to sleep restriction.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two days
This trial's timeline: 3 weeks for screening, Varies for treatment, and two days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cerebral blood flow velocity

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Restricted sleepExperimental Treatment1 Intervention
Participants will restrict sleep to four hours the night prior to the study visit.
Group II: Normal sleepPlacebo Group1 Intervention
Participants will sleep for 7-9 hours the night prior to the study visit.

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
362 Previous Clinical Trials
628,094 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study open to individuals who are aged 55 and above?

"This research is looking for participants aged 18 or above, but below 45."

Answered by AI

Is it possible to register for this clinical trial?

"This trial is open to patients aged between 18 and 45 with cerebrovascular disease, seeking a total of 20 participants."

Answered by AI

How many volunteers are participating in this trial?

"Indeed, according to clinicaltrials.gov the trial is currently open for enrollment. This study was posted on October 1st of 2023 and modified on October 27th with a goal of recruiting 20 individuals from one site."

Answered by AI

Is this research study still enrolling participants?

"Per the records hosted on clinicaltrials.gov, this research endeavour is presently recruiting participants. The trial was initially published at the beginning of October in 2023 and has most recently been revised in late October that same year."

Answered by AI
~4 spots leftby Jul 2024